Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2009-08-06
2011-12-06
Nolan, Jason M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S537000
Reexamination Certificate
active
08071638
ABSTRACT:
Atorvastatin potassium crystalline Forms A, B, E, F, and G are provided. Also provided are methods of preparing atorvastatin potassium crystalline Forms A, B, E, F, and G. Atorvastatin potassium crystalline Forms A, B, E, F, and G may be used to prepare pharmaceutical compositions useful for the treatment of hypercholesterolemia or hyperlipidemia.
REFERENCES:
patent: 4681893 (1987-07-01), Roth
patent: 5273995 (1993-12-01), Roth
patent: WO 2006/021216 (2006-03-01), None
U.S. Appl. No. 60/166,153, filed Nov. 17, 1999, Ayalon et al.
Kowalski Yoav
Levi Sigalit
Mittelman Ariel
Kenyon & Kenyon LLP
Nolan Jason M
Teva Pharmaceutical Industries Ltd.
LandOfFree
Solid states of atorvastatin potassium does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Solid states of atorvastatin potassium, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Solid states of atorvastatin potassium will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4316279